Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Pakistan

Pakistan

The Other Vaccines market in Pakistan is estimated to achieve a revenue of US$47.71m by 2024.
It is anticipated that the revenue will grow at an annual growth rate of 10.54% from 2024 to 2029, resulting in a market volume of US$78.73m by 2029.
When comparing this market globally, United States is expected to generate the highest revenue of US$24,730.00m in 2024.
Pakistan is experiencing a growing demand for other vaccines as the government focuses on expanding its immunization program.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Pakistan has been increasing over the years due to the country's growing population and the government's efforts to improve access to healthcare. The Other Vaccines market in Pakistan has also been experiencing growth, driven by various factors.

Customer preferences: Pakistan has a high incidence of infectious diseases, including hepatitis, typhoid fever, and polio. This has led to an increased demand for vaccines that can protect against these diseases. In addition, as the country's middle class grows, there is a greater awareness of the importance of preventive healthcare, including vaccination.

Trends in the market: The Other Vaccines market in Pakistan has been growing steadily in recent years, with a focus on vaccines for infectious diseases. In particular, there has been an increasing demand for vaccines that protect against hepatitis B and C, as well as typhoid fever. There has also been a growing interest in travel vaccines, as more Pakistanis travel abroad for work and leisure.

Local special circumstances: Pakistan faces unique challenges in ensuring access to vaccines for its population. These include a lack of infrastructure, particularly in rural areas, as well as a lack of awareness and education about the importance of vaccination. In addition, there have been concerns about the safety and efficacy of vaccines, which have led to some resistance to vaccination among certain segments of the population.

Underlying macroeconomic factors: Pakistan's growing population and economy are driving demand for vaccines, particularly as the middle class expands. The government has also been investing in healthcare infrastructure and increasing access to vaccines, which has helped to boost demand. However, the country still faces challenges in ensuring that all segments of the population have access to vaccines, particularly in rural areas.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.